The half-life of methylphenidate and dextroamphetamine salts very widely based on their formulations (they are not simply the numbers you posted). There are short, medium, and now long acting formulations for both, although the technology behind concerta (triple release methlyphenidate, very nifty) has not been brought over to dextroamphetamine yet as best I know.
One of the keys of ADHD is coming up with a regimen that fits that pt's life. Many do well on once daily dosing in the AM after breakfast, others have issues with appetite suppression and may need to stagger shorter acting formulations allowing time to eat in between.
Most research focuses with one of the two stimulants and not combining the two, which to the best of my knowledge has not been shown to be beneficial. Generally if a patient responds well to one or the other, there is a way to appropriately dose it to provide coverage for what they need.
Hope that helps answer your question.